Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA reviewing heart risks of Glaxo diabetes pill
FDA reviewing heart risks of Glaxo diabetes pill
FDA reviewing heart risks of Glaxo diabetes pill
Submitted by
admin
on April 13, 2013 - 12:11pm
Source:
Yahoo/AP
News Tags:
GSK
Avandia
diabetes
type 2 diabetes
Headline:
FDA reviewing heart risks of Glaxo diabetes pill
Do Not Allow Advertisers to Use My Personal information
